Progressive immune dysfunction with advancing disease stage in renal cell carcinoma

David A. Braun(Broad Institute), Kelly Street(Harvard University), Kelly P. Burke(Harvard University), David L. Cookmeyer(Harvard University), Thomas Denize(Brigham and Women's Hospital), Christina B. Pedersen(Copenhagen University Hospital), Satyen H. Gohil(Broad Institute), Nicholas R. Schindler(Dana-Farber Cancer Institute), Lucas Pomerance(Harvard University), Laure Hirsch(Harvard University), Ziad Bakouny(Dana-Farber Cancer Institute), Yue Hou(Dana-Farber Cancer Institute), Juliet Forman(Broad Institute), Teddy Huang(Dana-Farber Cancer Institute), Shuqiang Li(Broad Institute), Ang Cui(Broad Institute), Derin B. Keskin(Broad Institute), John A. Steinharter(Dana-Farber Cancer Institute), Gabrielle Bouchard(Dana-Farber Cancer Institute), Maxine Sun(Dana-Farber Cancer Institute), Erica Pimenta(Harvard University), Wenxin Xu(Harvard University), Kathleen M. Mahoney(Beth Israel Deaconess Medical Center), Bradley A. McGregor(Harvard University), Michelle S. Hirsch(Brigham and Women's Hospital), Steven L. Chang(Brigham and Women's Hospital), Kenneth J. Livak(Dana-Farber Cancer Institute), David F. McDermott(Beth Israel Deaconess Medical Center), Sachet A. Shukla(Broad Institute), Lars Rønn Olsen(Copenhagen University Hospital), Sabina Signoretti(Brigham and Women's Hospital), Arlene H. Sharpe(Brigham and Women's Hospital), Rafael A. Irizarry(Harvard University), Toni K. Choueiri(Harvard University), Catherine J. Wu(Broad Institute)
Cancer Cell
March 12, 2021
Cited by 505Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis